Monthly Archives: November 2023

Health Canada has approved Jamteki as the first biosimilar in Canada of ustekinumab for the treatment of psoriasis and psoriatic arthritis.  We expect that it will eventually be approved for Crohn’s Disease and Ulcerative Colitis as the originator ustekinumab (Stelara) … Continue reading →

Treating osteoporosis is vital to preventing fractures. Once a person has experienced a fracture of a weakened bone, especially after the age of 65, their risk of having another fracture in the next 1-2 years is greatly increased. Menopausal women … Continue reading →